Canada markets closed

Poseida Therapeutics, Inc. (PSTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.6450-0.0650 (-2.40%)
At close: 04:00PM EDT
2.6500 +0.01 (+0.19%)
After hours: 06:52PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
64,703
64,703
130,492
31,238
0
Operating Expenses
Research Development
156,772
156,772
152,899
136,734
103,520
Selling General and Administrative
37,435
37,435
37,539
35,915
23,029
Total Operating Expenses
194,207
194,207
190,438
172,649
126,549
Operating Income or Loss
-129,504
-129,504
-59,946
-141,411
-126,549
Interest Expense
8,671
8,671
6,370
3,358
3,506
Total Other Income/Expenses Net
14,852
14,852
2,858
19,795
280
Income Before Tax
-123,323
-123,323
-63,458
-124,974
-129,775
Income Tax Expense
107
107
544
0
0
Income from Continuing Operations
-123,430
-123,430
-64,002
-124,974
-129,775
Net Income
-123,430
-123,430
-64,002
-124,974
-129,775
Net Income available to common shareholders
-123,430
-123,430
-64,002
-124,974
-129,775
Basic EPS
-1.54
-1.37
-0.89
-2.01
-3.61
Diluted EPS
-1.54
-1.37
-0.89
-2.01
-3.61
Basic Average Shares
87,768
90,185
71,954
62,236
35,997
Diluted Average Shares
87,768
90,185
71,954
62,236
35,997